Back to top
more

Teva Pharmaceutical Industries (TEVA)

(Delayed Data from NYSE)

$16.25 USD

16.25
7,805,197

-0.01 (-0.06%)

Updated Jun 28, 2024 04:00 PM ET

After-Market: $16.25 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 249)

Industry: Medical - Generic Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

1 item in cart

View Cart/Checkout

Teva Pharmaceutical Industries Ltd. [TEVA]

Reports for Purchase

Showing records 281 - 300 ( 457 total )

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 281

02/20/2018

Company Report

Pages: 9

Price: 24.95

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 282

02/09/2018

Company Report

Pages: 2

Lowering to Hold On 2018 Outlook.

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 283

01/19/2018

Company Report

Pages: 10

Price: 24.95

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 284

01/12/2018

Company Report

Pages: 10

Price: 24.95

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 285

01/02/2018

Company Report

Pages: 10

Price: 24.95

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 286

12/19/2017

Company Report

Pages: 10

Price: 24.95

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 287

12/15/2017

Company Report

Pages: 2

The First Cut Is the Deepest - Buy

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 288

11/17/2017

Company Report

Pages: 9

Price: 24.95

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 289

11/03/2017

Company Report

Pages: 2

Teva Takes Another Tumble - Buy

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 290

10/20/2017

Company Report

Pages: 10

Price: 24.95

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 291

10/05/2017

Company Report

Pages: 2

The Copaxone Axe Finally Falls - Buy

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 292

10/05/2017

Company Report

Pages: 10

Price: 24.95

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 293

10/04/2017

Company Report

Pages: 10

Price: 24.95

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 294

09/21/2017

Company Report

Pages: 10

Price: 24.95

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 295

09/12/2017

Company Report

Pages: 2

The Danish Guy: Teva Names New CEO - Buy

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 296

08/21/2017

Company Report

Pages: 10

Price: 24.95

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 297

08/09/2017

Company Report

Pages: 10

Price: 24.95

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 298

08/08/2017

Company Report

Pages: 10

Price: 24.95

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 299

08/04/2017

Company Report

Pages: 2

Teva and the Terrible, Horrible, No Good, Very Bad Quarter

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Company: Teva Pharmaceutical Industries Ltd.

Industry: Medical - Generic Drugs

Record: 300

07/17/2017

Company Report

Pages: 10

Price: 24.95